Shares of Acelyrin tumbled after the company said it would stop developing its eye-disease treatment following results from a recent study. The stock fell 16%, to $3.39, in after-hours trading Tuesday ...
To relate laser eye surgery to cutting hair, painting nails, or giving a massage is a nonsensical comparison, yet some would-be reformers in West Virginia are using this flawed logic ...
"VisiRose is the bridge that connects innovation with impact. It enables us to bring the hope of RB PDAT to patients who desperately need it, transforming lives and shaping the future of eye care," ...
Bhatt, MD, MPH, MBA and Dipender Gill, MD, PhD join Cardiovascular Scientific Advisory Board – – Company nominates abdominal aortic aneurysm as second cardiovascular indication for pacibekitug, ...